
Sign up to save your podcasts
Or


Welcome to Automating Quality, the Life Sciences centric show that bridges the gap between automation and quality management systems. Philippe Gaudreau, CEO at SOLABS is your host for this episode!
We are joined today by Jamie Villeneuve, Owner and Head of Software Development at NexGen Analytics. Jamie will discuss the design of analytics from establishing the organization's goals to providing the right information to the right people at the right time.
Key Takeaways
01:58 Introducing today's guest: Jamie Villeneuve from NexGen Analytics
03:19 Who needs information from analytics in an organization?
05:36 How do you know what information is relevant to report on?
08:52 How do you communicate analytics effectively to all staff at a company?
11:40 Is there a process to review metrics over time and ensure what is measured stays up to date with the company's needs?
15:12 Thank you to Jamie for joining us!
Contact Jamie at [email protected]
Contact us at [email protected]
Welcome to Automating Quality, the Life Sciences centric show that bridges the gap between automation and quality management systems. Philippe Gaudreau, CEO at SOLABS is your host for this episode!
We are joined today by return guest Joseph Silvia, Director, Software Quality Training, and Instructor at Oriel STAT A MATRIX. In this episode, Joe shares his expertise on Supplier Management Quality for the medical devices industry. We discuss the onboarding process of new suppliers, the future of remote versus on-site audits, and more!
Key Takeaways
00:38 Introducing Joseph Silvia and Oriel STAT A MATRIX
02:53 Who are the main parties involved in the medical devices supply chain?
04:15 What is the process to getting a new supplier on board?
07:56 Are all audits in the future going to be remote?
10:04 Do suppliers change their processes to make themselves easier to audit?
12:55 Thanks to Joseph and our listeners for this great episode!
Welcome to Automating Quality, the Life Sciences centric show that bridges the gap between automation and quality management systems. Philippe Gaudreau, CEO at SOLABS is your host for this episode!
Our guest today is Joseph Silvia, Director, Software Quality Training and Instructor at Oriel STAT A MATRIX. Joe shares his expertise on the Case for Quality, what to focus on first when implementing a quality system and the differences between Computer Software Validation (CSV) and Computer Software Assurance (CSA), and more!
Key Takeaways
02:17 Introducing today's guest: Joseph Silvia, Director of Software Quality Training and Instruction and Lead Auditor at Oriel Stat A Matrix
03:33 What is the Case for Quality?
05:23 Joseph discusses the importance of having quality at the core of what you do as opposed to adding it as an afterthought
07:44 What is the first thing you should focus on when implementing a quality system?
10:55 Philippe shares his experience on implementing QM10 at SOLABS as part of our quality practices
12:53 The difference between Computer Software Validation (CSV) and Computer Software Assurance (CSA) and how this is impacting risk management
17:38 Thanking Joseph and our listeners for today's episode!
Contact Joseph at [email protected] or on LinkedIn
Oriel STAT A MATRIX: www.orielstat.com
Reach out to us at [email protected]
Welcome to Automating Quality. Mandy Gervasio is your host, and she's on a mission to bring you hot industry topics with her fellow life sciences partners and friends!
Today's episode features Steve Gens, Managing Partner at Gens & Associates. We will define data quality, what happens if the confidence in data quality is low, and provide some recommendations to keep it high.
Gens & Associates is a Life Science advisory and benchmarking firm founded in 2005 with a focus on the regulatory domain and adjacent areas (quality, clinical, safety). Their respected research community includes active clients and members from over 140 organizations that have participated in one of their 38 benchmark studies. They expanded their benchmark capability into quality with a landmark study in 2021.
Key Takeaways
00:49 Introducing today's guest: Steve Gens, here to discuss Data Quality with us
02:10 Defining Data Quality?
04:00 What happens when the confidence in the data quality is low?
05:48 Steve provides some recommendations related to Data Quality.
10:30 How does Data Quality bring Quality and Regulatory together?
13:26 what are some services Gens & Associates offer related to this topic?
Reach out to us at [email protected]
Welcome to Automating Quality. Mandy Gervasio is your host, and she's on a mission to bring you hot industry topics with her fellow life sciences partners and friends!
Today's episode features Steve Gens, Managing Partner at Gens & Associates. We will discuss the World Class RIM Benchmark conducted by Gens & Associates, how it came into being, and some of its key findings over time.
Gens & Associates is a Life Science advisory and benchmarking firm founded in 2005 with a focus on the regulatory domain and adjacent areas (quality, clinical, safety). Their respected research community includes active clients and members from over 140 organizations that have participated in one of their 38 benchmark studies. They expanded their benchmark capability into quality with a landmark study in 2021.
Key Takeaways
00:45 Introducing today's topic: The World Class RIM Benchmark by Gens & Associates
01:15 Steve Gens' Background
02:20 How did the World Class RIM come into being?
05:03 The origin of the RIM acronym
06:00 Steve shares some of the key findings of the benchmark over time
11:21 What does the industry need to get better?
13:10 Where does clinical stand compared to regulatory in terms of standardization
15:15 Is there a correlation between the ROI on new technology and having robust processes?
16:00 What has evolved over time in between those studies?
19:00 What would Steve recommend to students interested in the topic of RIM?
21:30 Thank you to our listeners!
Contact us at [email protected]
Welcome to Automating Quality. Mandy Gervasio is your host, and she's on a mission to bring you hot industry topics with her fellow life sciences partners and friends!
Today's episode features guest expert Ben Locwin! Ben is the VP of Project Solutions at Black Diamond Networks and has been working in the life sciences industry for over 25 years. Among other things, he has trained FDA inspectors and participated in the design of the Global Quality Metrics Initiative for the FDA.
The topic of today's episode is good machine learning practices for the medical devices industry. Ben discusses some good machine learning practices (GMLP) and discusses the importance of standardizing those across the industry over time.
Key Takeaways
01:00 Today's topic is good machine learning practices for the medical devices industry
01:20 Introducing today's guest: Ben Locwin
03:30 Ben introduces good machine learning practice guiding principles
06:43 How quickly will there be a set standardized framework for good machine learning practices (GMLP)?
11:10 Why this topic matters a lot
12:15 Will new competencies need to be developed for understanding the regulations and techniques in the field of machine learning?
14:36 Thank you to our guests and listeners!
Welcome to Automating Quality. Mandy Gervasio is your host, and she's on a mission to bring you hot industry topics with her fellow life sciences partners and friends!
Today's episode features guest expert Ben Locwin! Ben is the VP of Project Solutions at Black Diamond Networks and has been working in the life sciences industry for over 25 years. Among other things, he has trained FDA inspectors and participated in the design of the Global Quality Metrics Initiative for the FDA.
Today's topic of discussion is artificial intelligence and machine learning. Ben delivers some background on those buzzwords, how they relate to the FDA's action plan, how this will impact the medical device industry moving forward, and more!
Key Takeaways
01:22 Introducing today's guest Ben Locwin
03:26 Some background on artificial intelligence and machine learning
05:24 Common misunderstandings about those buzzwords
07:10 What is deep learning versus machine learning and AI?
08:43 How do these areas relate to the FDA's action plan?
14:05 How will this impact the medical device industry moving forward?
18:40 Mandy thanks Ben for joining us on the show
Welcome to Automating Quality. Mandy Gervasio is your host, and she's on a mission to bring you hot industry topics with her fellow life sciences partners and friends! In today's episode, we will discuss the discoveries of the Quality Benchmark conducted by Gens & Associates in late 2021.
Our guest today is Katherine Yang-Iott. She is a consultant and analyst for Gens and Associates and the study lead for the firm's first Quality-focused benchmark. She's had 2 decades of experience as a scientist and researcher.
Gens & Associates is a Life Science advisory and benchmarking firm founded in 2005 with a focus on the regulatory domain and adjacent areas (quality, clinical, safety). Their respected research community includes active clients and members from over 140 organizations that have participated in one of their 38 benchmark studies. They expanded their benchmark capability into quality with a landmark study in 2021.
Key Takeaways
01:32 Introducing today's guest: Katherine Yang-Iott, an Analyst at Gens & Associates
03:07 Katherine introduces Gens & Associates and the context of this study
06:07 What were the key findings of this survey?
08:50 What is a QMS in the perspective of Katherine
11:12 What was the goal of the study in terms of information produced?
14:20 How the pandemic has increased companies' focus on supplier management
20:00 Mandy mentions that CAPA is a quality process that companies still struggle to get right today
21:20 Philippe shares his thoughts on the benchmark's key learnings
22:57 What are the next steps for G&A in the world of quality?
25:15 Mandy thanks our guest and invites listeners to share their feedback
Welcome to Automating Quality. Mandy Gervasio is your host, and she's on a mission to bring you hot industry topics with her fellow life sciences partners and friends!
Today's episode features guest expert Ben Locwin! Ben is the VP of Project Solutions at Black Diamond Networks and has been working in the life sciences industry for over 25 years. Among other things, he has trained FDA inspectors and participated in the design of the Global Quality Metrics Initiative for the FDA.
The topic of today's discussion is the Real-World Evidence framework as defined by the FDA. We highly recommend listening to the previous episode on Real-World Data and Real-World Evidence before diving into this one.
Key Takeaways
00:17 Mandy introduces Ben back to the show
01:13 Today's topic is the Real-World Evidence framework
02:24 What is the FDA's definition of Real-World Evidence?
06:50 What is being looked at for the framework?
09:16 What are the 4 Vs of data?
11:18 How do you define your hypotheses in advance when looking at data?
15:44 Mandy reflects on today's discussion
Welcome to Automating Quality. Mandy Gervasio is your host, and she's on a mission to bring you hot industry topics with her fellow life sciences partners and friends!
Today's episode features a conversation with guest expert Ben Locwin. Ben is the VP of Project Solutions at Black Diamond Networks and has been working in the life sciences industry for over 25 years. Among other things, he has trained FDA inspectors and participated in the design of the Global Quality Metrics Initiative for the FDA.
The topic of today's discussion is about defining what are Real-World Data and Real-World Evidence (RWD & RWE).
Key Takeaways
01:13 Introducing today's guest: Ben Locwin
03:03 Philippe discusses the link between Real-World Data and its connection with technology
05:05 Ben defines Real-World Data and Real-World Evidence
10:28 Philippe discusses the importance of the integrity of data gathered from different sources
12:18 The importance of looking at the data with a specific hypothesis in mind
15:45 There is a lack of standardizing in data that leaves some concern
17:07 What is the FDA looking for regarding Real-World Data and Real-World evidence?
20:00 Ben shares his closing thoughts on the topic
Contact us at [email protected]
From the publisher's feed